Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE DLC-1 may be a tumor suppressor gene in liver cancer as well as in other cancers. 9605766 1998
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE The delineation of the gene structure allows mutation analysis of DLC1 in other tumour types for which it remains a candidate tumour suppressor gene based on its location and homology to rhoGAP. 10649492 2000
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE DLC-1 (deleted in liver cancer 1) is a candidate tumor suppressor gene for hepatocellular carcinoma and other cancers. 12034501 2002
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE DLC2 is homologous to DLC1, a previously identified tumor suppressor gene at 8p22-p21.3 frequently deleted in HCC. 12531887 2003
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE Furthermore, introduction of the DLC-1 cDNA abolished the in vivo tumorigenicity in nude mice, suggesting that the DLC-1 gene plays a role in breast cancer by acting as a bona fide tumor suppressor gene. 12545165 2003
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 PosttranslationalModification group BEFREE To determine whether aberrant methylation is a contributing factor to transcriptional inactivation of DLC-1 (deleted in liver cancer-1), a candidate tumor suppressor gene, we examined its methylation status in twelve hepatocellular carcinoma. breast, colon, and prostate tumor cell lines with low or undetectable expression of DLC-1. 12645648 2003
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE The DLC-1 gene, located on 8p21-p22, might be a candidate tumor suppressor gene in this region. 12759748 2003
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 AlteredExpression group BEFREE While the pathogenic relevance of the intronic polymorphism is not known, the low rate of mutation of the DLC-1 gene in HCC implies that genomic deletion and promoter methylation primarily account for the altered expression and tumor suppressive inactivation of the DLC-1 gene. 12792785 2003
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE DLC1 (deleted in liver cancer), a gene in this interval, has been proposed as a candidate tumor suppressor gene because of its homology (86% similarity) with rat p122 RhoGAP, which catalyzes the conversion of active GTP-bound rho complex to the inactive GDP-bound form, and thus suppresses Ras-mediated oncogenic transformation. 12873722 2003
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 AlteredExpression group BEFREE The results show that Dlc-1protein is localized in the cell cytoplasm, and the restoration of DLC-1 expression in HCC cells resulted in caspase-3-mediated apoptosis, inhibition of cell growth and invasiveness in vitro as well as in reduction of the ability of the cells to form tumors in athymic nude mice. 14647417 2004
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. 14661059 2004
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 PosttranslationalModification group BEFREE In order to determine whether inactivation of DLC1 is involved in HNSCC, we have screened tumour cell lines for DLC1 mutations and expression. 15159023 2004
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 AlteredExpression group BEFREE Absence or low expression of DLC-1, a tumor suppressor gene, in breast cancers has been shown recently. 15201975 2004
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE The aim of this study was to evaluate whether DLC-1, a newly identified tumor-suppressor gene on chromosome 8p22, is involved in the tumorigenesis of MBs and the histologically similar SPNETs. 15712180 2005
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE Deleted in liver cancer-1 (DLC-1) is a tumour suppressor gene that is inactive in liver carcinogenesis. 16489177 2006
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 GeneticVariation group BEFREE The deleted in liver cancer-1 (DLC-1) gene that encodes a Rho GTPase-activating protein with tumor suppressor function is located on chromosome 8p21-22, a region frequently deleted in prostate carcinomas. 16533763 2006
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE Taken together, our results suggest that DLC-1 might be an NPC-related tumor suppressor gene affected by aberrant promoter methylation and gene deletion. 16680376 2006
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE The methylation of the candidate tumor suppressor gene DLC-1 was detected in a high proportion of primary tumor and plasma DNA samples by using quantitative methylation-specific PCR analysis. 16774933 2007
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE DLC1 appears to be a major TSG implicated in the pathogenesis of these tumors, and should be further tested as a molecular biomarker in patients with these cancers. 16862168 2007
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. 16951145 2006
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 AlteredExpression group BEFREE This comparative expression analysis of DLC-1 and -2 identifies down-regulation of the two emerging bona fide tumor suppressor genes in additional types of solid tumors. 17016643 2006
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 PosttranslationalModification group BEFREE Aberrant DLC1 methylation appeared to be a relatively early event during renal tumorigenesis since 33% of the RCC tumors with pT1 (TNM staging) showed methylation, which is similar to other late stage tumors. 17029774 2007
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE DLC-1 (deleted in liver cancer-1) is a tumor suppressor gene for hepatocellular carcinoma and other cancers. 17292327 2007
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE Two related Rho GTPase-activating proteins, DLC-1 (deleted in liver cancer 1) and DLC-2, are emerging as bona fide tumor suppressor genes that inhibit cancer cell growth. 17297465 2007
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE More than a 10-fold increase in mRNA expression was observed for two previously identified tumor suppressor genes (DLC-1 and DCC) and also for RPIB9 and PCDHGA12. 17363581 2007